Twitxy Saved

Jonathan Foulds PhD

Verified account This account is verified. Learn more

@JonathanFoulds

Professor of Public Health Sciences at Penn State University, College of Medicine. President-Elect, Society for Research on Nicotine & Tobacco (views mine only)
Hershey, Pennsylvania, USA scholar.google.com/citations?user… Joined March 2011
1.5K Following 2.8K Followers 11K Posts

Latest posts 5

Jonathan Foulds PhD Verified account @JonathanFoulds
Lars Ramstrom (1931-2026), a giant in tobacco research, passed away earlier this month at the age of 95.
Originally trained in mathematics and natural sciences he first became involved in tobacco research in the 1970’s, publishing articles on smoking and lung cancer, encouraging the medical profession to help patients who smoke to quit, and writing on the harms of passive smoking. He was Secretary General of the Fourth World Conference on Smoking and Health in Stockholm in 1979, and in 1988 he was the recipient of a WHO Award for achievements in Tobacco Control.
One of his earliest papers (1990) on Swedish snus (moist oral smokeless tobacco) acknowledged that it has a lower cancer risk than smoking but warned that in young people it could be the first step on towards taking up cigarettes (1). However, he continued to monitor the patterns of cigarette smoking and snus use among men and women in Sweden along with the patterns of smoking-related diseases and became more and more convinced by the emerging data that among men in particular, use of snus was directly replacing cigarette smoking and lowering smoking-caused mortality. In a letter published in The Lancet in 1992, co-authored with Karl Fagerstom and Torgny Svensson, (in the context of a ban on the sale of oral tobacco products in the European Union), Ramstrom and his colleagues outlined the basic guiding principle of tobacco harm reduction:
“Tobacco control efforts should be based on a comprehensive combination of various strategies…..to obtain the best reduction of tobacco-related morbidity and mortality and, thus, to promote health.” (2)
As they recommended, Sweden obtained an exemption from the smokeless tobacco ban when it joined the EU in 1995.
Lars became a member of SRNT in 1998 and from the beginning of the 21st century he collaborated with a host of Swedish and international colleagues in publishing a series of papers demonstrating that in Sweden the availability of snus appears to have contributed to unusually low rates of smoking among men, with a corresponding reduction in rates of lung cancer and myocardial infarction (3,4,5).
Lars Ramstrom was the winner of the 2018 Michael Russell Award in recognition of his contribution to tobacco harm reduction through science and scholarship. One of his nomination letters stated:
“ It takes an extraordinary openness to facts and a lot of personal courage for a Swedish scientist to change their mind and take a harm reduction approach in tobacco at the age of 65, after 25 years in tobacco control. It takes heroism and true dedication to health to actively continue to defend that position in a person at the age of 86 with comprehensive and always compelling analysis of the latest data."
The comment about personal courage reflects the reality that many colleagues in tobacco control both in Sweden and abroad were critical of his evidence-based focus on improving health. Although Lars Ramstrom’s work was not funded by any tobacco companies, he may have taken some satisfaction when in 2015 General Snus was the first tobacco product to be authorized for marketing in the United States via a pathway requiring strong evidence that its sale on the US market is “appropriate for the protection of public health”. In 2019, after many years of thorough review of the evidence by FDA, General Snus was also the first product to obtain a “Modified Risk” designation from FDA, allowing the manufacturer to state on its US tins that:
“Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” (6)
In 2025 daily snus prevalence in Sweden was 15% and daily cigarette smoking was 3.7% (7), the lowest daily smoking rate in Europe. Sweden also continues to have the lowest rates of smoking-related mortality in Europe including unusually low rates of oral and lung cancer. Lars Ramstrom published his last journal article on snus and public health in 2024 when he was 93 (8). His brave and diligent research over decades made a great contribution to our understanding of the potential societal health effects of lower risk nicotine products and the lessons to be learned from the Swedish Experience. He truly was a pioneer.
1. Nordgren P, Ramstrom 1990 pubmed.ncbi.nlm.nih.gov/2224190/
2. Fagerstrom KO, Ramstrom LM, Svensson TH 1992. pubmed.ncbi.nlm.nih.gov/1348327/
3. Foulds J, Ramstrom L, Burke M, Fagerstrom K 2003. pubmed.ncbi.nlm.nih.gov/14660766/
4. Ramstrom LM, Foulds J. 2006. pubmed.ncbi.nlm.nih.gov/16728752/
5. Ramstrom L, Borland R, Wilkmans T 2016. pubmed.ncbi.nlm.nih.gov/27834883/
6. FDA 2019. prnewswire.com/news-releases/…
7. Swedish Council for Information on Alcohol and Other Drugs (CAN) can.se/app/uploads/20…
Ramstrom LM. 2024 pubmed.ncbi.nlm.nih.gov/39327580/
pubmed.ncbi.nlm.nih.gov Moist snuff in Sweden--tradition and evolution - PubMed Snuff-dipping was already widespread in Sweden in the 19th century. After the 1920s snuff sales went down, but Sweden still kept its position as world leader in per capita consumption of moist snuff....